This share prices have a 15 minute delay and are shown in the local time of the market in which the quote is displayed.
The Santander X Global Challenge | Innovation in Healthcare lauded some of the most disruptive business in healthcare. Over 790 startups and scaleups from 11 countries participated in the challenge, with total prizes amounting to €120,000.
Improving people’s health has long been an objective for companies and governments worldwide. That’s why developing innovative solutions in patient care, cost reduction and greater healthcare system efficiency are key.
in prizes, as well as access to Santander X 100 and other benefits
in prizes, as well as access to Santander X 100 and other benefits
At Santander, we share this objective. For example, we participated from the beginning in the PESA CNIC-Santander study, which began 14 years ago to identify, diagnose and treat cardiovascular diseases, the leading cause of death in the world.
We have also focused on helping health sector entrepreneurs grow through initiatives such as the Santander X Global Challenge | Innovation in Healthcare. This international competition, run in collaboration with Oxentia Foundation and Hitachi, selected and rewarded three innovative, cutting-edge startups and three equally groundbreaking scaleups in healthcare services.
Winners of the Santander X Global Challenge | Innovation in Healthcare
“Startups”
- Cardiology Devices (United Kingdom) – Creators of a groundbreaking device that treats advanced heart failure and may be particularly suitable for the elderly.
- BioTryp Therapeutics (United Kingdom) – Developers of technology to treat infections as an alternative to traditional antibiotic treatments.
- Feyenally (Poland) – Owners of an original app that performs remote eye examinations using a mobile phone.
“Scaleups”
- Mendelian (United Kingdom) – Creators of an algorithm that enables early identification of rare diseases by doctors. They achieve this through codification of the diagnostic criteria in more than 100 cases.
- CanCertain Limited (United Kingdom) – Developers of personalized tests based on 3D cell cultures that enable identification of the most suitable treatment for patients within eight days.
- Bitbrain (Spain) – Inventors of neurotechnology devices that enable brain and body monitoring via electroencephalogram (EEG), supported by AI powered software.
These three startup and three scaleup winners of the global challenge earned €120.000 in prizes, in addition to recognition of their projects and access to the exclusive Santander X community, where they can connect with other entrepreneurs, mentors, experts, investors and clients, as well as access resources, exclusive events and on-demand support free of charge.
To select the six winning projects, a jury of experts made up of executives from Banco Santander — including members from our Corporate & Investment Banking (CIB) global business — and other internationally renowned organizations assessed and validated the proposals.
This edition, like the other global challenges we launch annually, has attracted great interest in the business ecosystem: We welcomed the participation of more than 790 companies from 11 countries.
